The most frequent MPN are essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), which present a high incidence of JAK2 activating mutations (i. e. JAK2V617F, indel CALR, and MPL mutations)2. Here, JAK2 is linked to myeloproliferative disorder.